RAYMOND JAMES & ASSOCIATES - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$671,000
+14.1%
163,623
-0.7%
0.00%
Q4 2021$588,000
-4.4%
164,782
-2.5%
0.00%
-100.0%
Q3 2021$615,000
-21.1%
169,001
-5.4%
0.00%0.0%
Q2 2021$779,000
-5.0%
178,566
-10.5%
0.00%0.0%
Q1 2021$820,000
+17.1%
199,413
+13.7%
0.00%0.0%
Q4 2020$700,000
+46.8%
175,340
-0.7%
0.00%0.0%
Q3 2020$477,000
-16.2%
176,594
-14.7%
0.00%0.0%
Q2 2020$569,000
+34.8%
207,018
+15.8%
0.00%0.0%
Q1 2020$422,000
-22.6%
178,770
+54.2%
0.00%0.0%
Q4 2019$545,000
+289.3%
115,909
+177.9%
0.00%
Q3 2019$140,000
+2.9%
41,705
+0.7%
0.00%
Q2 2019$136,000
+15.3%
41,416
+6.8%
0.00%
Q1 2019$118,000
+15.7%
38,793
+3.6%
0.00%
Q4 2018$102,000
+343.5%
37,449
+230.7%
0.00%
Q4 2017$23,000
-37.8%
11,3230.0%0.00%
Q3 2017$37,000
+15.6%
11,323
+12.2%
0.00%
Q2 2017$32,00010,0920.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders